Insulin Producing Cells En-Masse

Scientists have accelerated stem cell differentiation to produce more insulin-producing beta cells.

Harvard University researchers have developed a technique to accelerate stem cell differentiation to produce massive amounts of the insulin-producing beta cells that are destroyed in patients with type-1 or type-2 diabetes.  With an ample and readily available supply of beta cells, researchers are developing therapies that may someday allow patients to produce the precise amount of insulin required to control their blood sugar levels naturally – without the use of a pump or insulin shots.

According to Albert Hwa, director of the diabetes advocacy group JDRF that funded the research, “This is part of the holy grail of regenerative medicine or tissue engineering, trying to make an unlimited source of cells or tissues or organs that you can use in a patient to correct a disease.”  While the technology is currently being used to test diabetes treatments, scientists can capitalize on the advance  by regenerating large amounts of cells or tissues to develop therapies for patients suffering from a wide range of diseases, traumas, and injuries.

As regenerative engineering progresses, we believe the best stem cells to use in emerging treatments will be the patient’s own [autologous stem cells] as this negates the need to find a suitable donor and eliminates the chances of rejection of the transplanted tissue. To learn more about banking your own valuable stem cells to insure your family’s future health, visit StemSave or call 877-783-6728 (877-StemSave) today.

 

 

To view the full article, click here.

 

 

The Future of Regenerative Medicine is Now™